Literature DB >> 3142543

Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus.

M Walters1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142543      PMCID: PMC1834410          DOI: 10.1136/bmj.297.6651.773

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Pharmacology of the ductus arteriosus.

Authors:  R I Clyman; M A Heymann
Journal:  Pediatr Clin North Am       Date:  1981-02       Impact factor: 3.278

2.  Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus.

Authors:  P Vert; G Bianchetti; F Marchal; P Monin; P L Morselli
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

3.  Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus.

Authors:  M S Corazza; R F Davis; T A Merritt; R Bejar; W Cvetnic
Journal:  J Pediatr       Date:  1984-08       Impact factor: 4.406

  3 in total
  3 in total

1.  Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin.

Authors:  R C Coombs; M E Morgan; G M Durbin; I W Booth; A S McNeish
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  Excretion of indomethacin in breast milk.

Authors:  T H Lebedevs; R E Wojnar-Horton; P Yapp; M J Roberts; L J Dusci; L P Hackett; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

Review 3.  Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.

Authors:  C Herrera; J Holberton; P Davis
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.